Tagrisso

Product: TAGRISSO

Manufacturer: ASTRAZENECA

Generic: Osimertinib

Type: Hard Capsules

Strength: Tagrisso 40 / 80 mg Tablet

Packing: Pack of 28 Capsules

Description: It is used to treat non-small cell lung cancer and given to adult patients who have certain EGFR mutations.

Indication: Non-small cell lung cancer

Use of Tagrisso 40 / 80 mg Tablet

This is an anti-cancer medication that is used for treat non-small cell lung cancer, works as the blocking of abnormal protein that signals cancer cells to multiply.

Side Effects of the Tagrisso 40 / 80 mg Tablet

Major & minor side effects for Tagrisso 40 / 80 mg Tablet

• Diarrhea
• Stomatitis (Inflammation of the mouth)
• Rash
• Loss of appetite

When not to use?

This tablet is not suggested for use in patients with a known allergy to Osimertinib or any other inactive ingredients present along with it.

Warning

• Pregnancy
  It is unsafe to give it to pregnant women. Please seek the advice of doctor for further info.
• Breast-feeding
  It is unsafe to use during breast-feeding, the drug may cause toxicity to the baby.
• Alcohol
  Contact with alcohol is mysterious. Please seek advice from your doctor.
• Driving or operating machinery
  Do not drive or operate machine unless you are feeling well, and Infusion may cause side effects which could affect your ability to drive or operate machine.
• Kidney
  There is no data available. Please seek advice from doctor before consuming the drug.
• Liver
  There is no data available. Please seek advice from doctor before consuming the drug.